Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Thailand

Thai FDA registration enables marketing, while public reimbursement is principally shaped through the National List of Essential Medicines, with expert review, HTA for high-impact medicines and scheme implementation.

Thai FDA

NLEM expert panels

HITAP / NLEM working groups

NLEM subcommittee / NHSO

Public schemes / providers

5 decision nodes15 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it